Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Mitochondrial enzyme SIRT5 regulates proteins involved in metabolism

The Sirtuin family of protein deacylases has received considerable attention in recent years due to its links to longevity, diabetes, cancer, and metabolic regulation.

12 Dec 2013

Two tumor-suppressing genes could play vital role in controlling obesity, cancer, diabetes

The function of two tumor-suppressing genes could play a vital role in helping to control obesity and other diseases such as diabetes, heart disease and cancer, according to researchers in Temple University's Sbarro Institute for Cancer Research and Molecular Medicine.

12 Dec 2013

Study finds link between consumption of foods from restaurants and obesity risk in African Americans

Americans are increasingly eating more of their meals prepared away from home, and this is particularly true among African Americans, who also have higher rates of obesity than other Americans. Young adults tend to eat out more often at fast-food restaurants and these establishments are more often found in minority neighborhoods.

12 Dec 2013

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

A team of researchers from Brigham and Women's Hospital, Boston Medical Center and Massachusetts General Hospital has been awarded $25 million by the National Institutes of Health to conduct a four-year, randomized clinical trial-the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia). The trial will compare traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia.

11 Dec 2013

Echo Therapeutics signs strategic collaboration agreement with MTIA

Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.

10 Dec 2013

Findings hold great promise for potential use of ELABELA as therapeutic molecule for heart diseases

Scientists at A*STAR's Institute of Medical Biology and Institute of Molecular and Cellular Biology have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.

9 Dec 2013

Scientists identify gene encoding hormone to treat heart diseases

Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases.

9 Dec 2013

Low vitamin D levels: Not a cause but a consequence of ill health

A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson’s disease, and even death.

6 Dec 2013

Hypertension skyrocketing in India

Hypertension is skyrocketing in India, with rural-to-urban migrants at especially high risk. Hypertension will be a key theme at the 65th Annual Conference of the Cardiological Society of India, which takes place during 5-8 December in Bangalore, India, and features a collaborative programme with the European Society of Cardiology.

6 Dec 2013

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

5 Dec 2013

Type 2 diabetes management: an interview with Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim

The rate of Type 2 Diabetes is rapidly increasing, particularly in Asian countries which make up more than 60 percent of the world’s diabetes population. So it’s really important physicians feel confident managing this chronic condition in their daily clinical practice.

5 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Long-term untreated PTSD symptoms may increase risk of cardiovascular health

There is growing concern that long-term untreated posttraumatic stress disorder (PTSD) symptoms may increase the risk of developing a number of medical problems, particularly compromised cardiovascular health.

2 Dec 2013

Hypertension organ risk revealed in Chinese patients

A study of Chinese patients warns of the risk for target organ damage from untreated hypertension, especially for younger patients.

2 Dec 2013

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered include breast density legislation, digital breast tomosynthesis (or 3-D mammography), lung cancer screening and computed tomography colonography reimbursement.

2 Dec 2013

Esaote to showcase Prevention Suite for cardiovascular assessment at EuroEcho-Imaging conference

This year’s EuroEcho-Imaging conference in Istanbul, Turkey (11-14 December) will see global medical imaging manufacturer, Esaote, showcase Prevention Suite: a unique package of ultrasound imaging modalities for both cardiac and vascular investigations. Prevention Suite provides clinicians with a wide range of tools for assessing a patient’s risk of cardiovascular disease quickly and reliably, often before symptoms occur. It is regarded as providing a ‘step change’ in terms of early detection and prevention of cardiovascular disease using ultrasound.

30 Nov 2013

Pivotal Therapeutics reports financial results for Q3 2013

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies announced its third quarter financial results and operational highlights for the three and nine months ended September 30, 2013.

30 Nov 2013

Poor oral hygiene, excess sugar consumption linked to heart disease

The association between poor oral health and increased risk of cardiovascular disease should make the reduction of sugars such as those contained in junk food, particularly fizzy drinks, an important health policy target, say experts writing in the Journal of the Royal Society of Medicine.

28 Nov 2013

Advances in cardiovascular sciences to be discussed at University of Leicester

Advances in Cardiovascular Sciences are to be showcased in two public lectures at the University of Leicester.

27 Nov 2013

More nuts, more health benefits

In a large new study, observational researchers at Harvard University looked at how eating nuts may help reduce the risk of mortality, finding that those who ate nuts daily, such as pistachios, saw health benefits nearly double.

27 Nov 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Mitochondrial enzyme SIRT5 regulates proteins involved in metabolism

Two tumor-suppressing genes could play vital role in controlling obesity, cancer, diabetes

Study finds link between consumption of foods from restaurants and obesity risk in African Americans

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

Echo Therapeutics signs strategic collaboration agreement with MTIA

Findings hold great promise for potential use of ELABELA as therapeutic molecule for heart diseases

Scientists identify gene encoding hormone to treat heart diseases

Low vitamin D levels: Not a cause but a consequence of ill health

Hypertension skyrocketing in India

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

Type 2 diabetes management: an interview with Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Long-term untreated PTSD symptoms may increase risk of cardiovascular health

Hypertension organ risk revealed in Chinese patients

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

Esaote to showcase Prevention Suite for cardiovascular assessment at EuroEcho-Imaging conference

Pivotal Therapeutics reports financial results for Q3 2013

Poor oral hygiene, excess sugar consumption linked to heart disease

Advances in cardiovascular sciences to be discussed at University of Leicester

More nuts, more health benefits

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in